Clinical Trial Update: R-5280 in Newly Diagnosed Patients With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial of R-5280 in newly diagnosed Type 1 diabetes mellitus has completed enrollment; no efficacy results are reported in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• R-5280

Snippet

Sponsor: Rise Therapeutics LLC | Conditions: Type 1 Diabetes, Type 1 Diabetes (Juvenile Onset) | Phase 1 | Status: COMPLETED